Lantheus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lantheus and other ETFs, options, and stocks.

About LNTH

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. 

CEO
Mary Anne Heino
CEOMary Anne Heino
Employees
1,193
Employees1,193
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
1956
Founded1956
Employees
1,193
Employees1,193

LNTH Key Statistics

Market cap
6.71B
Market cap6.71B
Price-Earnings ratio
24.18
Price-Earnings ratio24.18
Dividend yield
Dividend yield
Average volume
1.19M
Average volume1.19M
High today
$103.75
High today$103.75
Low today
$100.68
Low today$100.68
Open price
$101.20
Open price$101.20
Volume
279.66K
Volume279.66K
52 Week high
$103.89
52 Week high$103.89
52 Week low
$47.25
52 Week low$47.25

Stock Snapshot

With a market cap of 6.71B, Lantheus(LNTH) trades at $103.07. The stock has a price-to-earnings ratio of 24.18.

As of 2026-06-04, Lantheus(LNTH) stock has fluctuated between $100.68 and $103.75. The current price stands at $103.07, placing the stock +2.4% above today's low and -0.7% off the high.

The Lantheus(LNTH)'s current trading volume is 279.66K, compared to an average daily volume of 1.19M.

During the past year, Lantheus(LNTH) stock moved between $47.25 at its lowest and $103.89 at its peak.

During the past year, Lantheus(LNTH) stock moved between $47.25 at its lowest and $103.89 at its peak.

LNTH News

Simply Wall St 2h
How Investors Are Reacting To Lantheus Holdings Award-Winning Thrombus-Specific PET/CT Diagnostic Breakthrough - simplywall.st

...

How Investors Are Reacting To Lantheus Holdings Award-Winning Thrombus-Specific PET/CT Diagnostic Breakthrough - simplywall.st
Simply Wall St 5d
Assessing Lantheus Holdings Valuation As New ASCO 2026 Oncology Data Nears Publication

Lantheus Holdings (LNTH) is drawing fresh attention after announcing that new clinical and real world oncology data will be featured at the 2026 American Societ...

Assessing Lantheus Holdings Valuation As New ASCO 2026 Oncology Data Nears Publication
Simply Wall St 6d
Lantheus ASCO Data To Test Radiopharma Pipeline And Valuation Gap Narrative

Lantheus Holdings (NasdaqGM:LNTH) plans to present new clinical data for LNTH-2403, an LRRC15-targeted radiopharmaceutical, at the 2026 ASCO Annual Meeting. Th...

Lantheus ASCO Data To Test Radiopharma Pipeline And Valuation Gap Narrative

Analyst ratings

79%

of 14 ratings
Buy
78.6%
Hold
21.4%
Sell
0%

People also own

Based on the portfolios of people who own LNTH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.